Maternal smoking and craniosynostosis

K Källén1

  • 1Tornblad Institute, University of Lund, Lund S-223 62, Sweden. karin.kallen@anatom.lu.se

Teratology
|September 3, 1999
PubMed

To investigate a possible association between maternal smoking during pregnancy and craniosynostosis (premature closure of one or more of the cranial sutures), a study was conducted using Swedish health registries. Infants with craniosynostosis (n = 304) without a known chromosome anomaly were selected among 1,413,811 infants born between 1983-1996 with known smoking exposure in early pregnancy. A statistically significant association between maternal smoking and craniosynostosis was found (adjusted odds ratio (OR), 1.45; 95% confidence interval (CI), 1.13-1.87), but this association was only valid for isolated defects (OR, 1.67; 95% CI, 1.27-2.19). For associated craniosynostosis (malformation syndromes included), a negative (nonsignificant) association with maternal smoking was indicated instead. For isolated craniosynostosis (all types), a dose-dependent effect of maternal smoking was indicated (OR and 95% CI for smoking <10 cigarettes/day, 1.45 (1.04-2.02); OR and 95% CI for smoking >/=10 cigarettes/day, 2.12 (1.50-2.99)), but was not statistically significant. Among the different types of craniosynostosis, premature closure of the sagittal suture showed the strongest association with maternal smoking (OR, 1.48; 95% CI, 1. 02-2.14), whereas for coronal suture defects, no association with maternal smoking could be detected (OR, 1.02; 95% CI, 0.47-2.21). As no obvious confounders were detected, the present study supports an earlier report of an association between maternal smoking during pregnancy and at least some types of craniosynostosis.

Related Concept Videos

Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...